Price $8.89 |
Market Cap
409.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
22.04
|
P/S
3.42
|
Dividend %
-
|
|
P/CF
23.8
|
P/FCF
-
|
Op. Cash Flow
-48.6K
|
FCF
-1.0
|
|
Op. Margin
-46.70%
|
Net Margin
-56.20%
|
ROE
-184.70%
|
ROI
-48.20%
|
|
ROA
-41.10%
|
EPS Growth
15.90%
|
Current Ratio
3.0
|
Debt/Equity
122.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Elite Pharmaceuticals Inc (ELTP) | $0.06 | - | - | 57.6M | Strong Buy |
| CytomX Therapeutics Inc (CTMX) | $6.65 | - | - | 319.2M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.44 | - | - | 15.8M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.35 | - | - | 44.2M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $9.12 | - | - | 10.2B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
